DePuy Synthes receives European CE Mark for new BI-MENTUMTM Dual Mobility System
Johnson & Johnson Medical Devices Companies today announces that DePuy Synthes, a leader in the cementless hip implant market, has obtained the European CE Mark on its new BI-MENTUMTM Dual Mobility System for use in patients with a higher risk of dislocation. BI-MENTUM features a standard femoral head articulating within a large polyethylene liner which then swivels within a metal shell. The system is designed to reduce the risk of dislocation, which can impact patient satisfaction and result in later revision costs.
More than three million hip arthroplasties have been registered in Europe since 1975. The incidence of instability caused by dislocation after Total Hip Arthroplasty (THA) in the primary and revision setting has been reported to be as high as 7% and 25%, respectively. Instability can have a significant impact on patients’ quality of life and mobility. In addition to the burden of repeat surgeries, dislocation can also impact costs in a resource-constrained environment. In fact, the surgical treatment of a dislocating THA can raise the cost of hip replacement by 342%.